Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK). The first 'Breakthrough Device Designation' received by Concept Medical Inc. was on 30th April 2019 for its MagicTouch SCB, for the treatment of Coronary Artery Disease (CAD) in patients with in-stent restenosis.
Read MoreThe study suggests that the compounds that are naturally occurring, biologically active, and derived from omega-3 PUFAs reduce inflammation and improve the healing of blood vessels after injury.
Read MoreTemecula Valley Hospital becomes the third Universal Health Services (UHS) facility in the Southern California region to implement the Digisonics cardiovascular information system for structured reporting.
Read MoreTarget Meeting specializes in organizing 1st world cardiovascular, diabetes, and obesity online conference, which will be held on September 22-24, 2011. It will be an innovative, informative, and interesting online conference without travel.
Read More